Exiqon Q3 Revenues Climb 10 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Exiqon today reported a 10 percent increase year over year in its third quarter revenues.

For the three months ended Sept. 30, Exiqon's total revenues increased to DKK 38.4 million ($5.7 million) from DKK 34.8 million in the prior-year period.

In a statement, the Danish firm said that product sales increased 29 percent to DKK 24.7 million from DKK 19.1 million in 2014.

The firm's net income for the quarter was down to DKK 727,000, or DKK .02 per share, compared to a profit of DKK 1.7 million, or DKK .04 per share, in Q3 2014.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.